The ICAD chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ICAD chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ICAD stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ICAD Detailed Price Forecast - CNN Money||View ICAD Detailed Summary - Google Finance|
|View ICAD Detailed Summary - Yahoo! Finance||View ICAD Stock Research & Analysis - Zacks.com|
|View ICAD Trends & Analysis - Trade-Ideas||View ICAD Major Holders - Barrons|
|View ICAD Call Transcripts - NASDAQ||View ICAD Breaking News & Analysis - Seeking Alpha|
|View ICAD Annual Report - CompanySpotlight.com||View ICAD OTC Short Report - OTCShortReport.com|
|View ICAD Fundamentals - TradeKing||View ICAD SEC Filings - Bar Chart|
|View Historical Prices for ICAD - The WSJ||View Performance/Total Return for ICAD - Morningstar|
|View the Analyst Estimates for ICAD - MarketWatch||View the Earnings History for ICAD - CNBC|
|View the ICAD Earnings - StockMarketWatch||View ICAD Buy or Sell Recommendations - MacroAxis|
|View the ICAD Bullish Patterns - American Bulls||View ICAD Short Pain Metrics - ShortPainBot.com|
|View ICAD Stock Mentions - StockTwits||View ICAD Stock Mentions - PennyStockTweets|
|View ICAD Stock Mentions - Twitter||View ICAD Investment Forum News - Investor Hub|
|View ICAD Stock Mentions - Yahoo! Message Board||View ICAD Stock Mentions - Seeking Alpha|
|View Insider Transactions for ICAD - SECform4.com||View Insider Transactions for ICAD - Insider Cow|
|View ICAD Major Holdings Summary - CNBC||View Insider Disclosure for ICAD - OTC Markets|
|View Insider Transactions for ICAD - Yahoo! Finance||View Institutional Holdings for ICAD - NASDAQ|
|View ICAD Stock Insight & Charts - FinViz.com||View ICAD Investment Charts - StockCharts.com|
|View ICAD Stock Overview & Charts - BarChart||View ICAD User Generated Charts - Trading View|
NASHUA, N.H. and ATHENS, Greece, Oct. 11, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced outstanding clinical results of its new, leading-edge digital breast tomosynthesis (DBT) cancer detection software. The study demonstrated significant positive results for clinical performance and workflow efficiency.
SUNY Upstate Medical University Selects iCAD’s Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment
Posted on Tuesday October 09, 2018
NASHUA, N.H. and SYRACUSE, N.Y., Oct. 09, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that its Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is now available at Upstate Medical University. Affiliated with the State University of New York, Upstate Cancer Center is the first facility in central New York State to offer treatment of early-stage breast cancer using intraoperative radiation therapy (IORT) with the advanced Xoft System.
Sanford Health Announces Adoption of iCAD's Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment
Posted on Wednesday October 03, 2018
The new treatment of early-stage breast cancer using intraoperative radiation therapy (IORT) with the leading-edge Xoft System is a first for South Dakota and is offered through the Edith Sanford Breast Center. The medical facility is part of Sanford Health, the largest rural, not-for-profit healthcare system in the nation with 39 hospitals and 225 clinics serving 126 communities across nine states.
NASHUA, N.H., Oct. 01, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the results of a long-term, independent study conducted with the Xoft® Axxent® Electronic Brachytherapy (eBx®) System® for the treatment of early-stage breast cancer using intraoperative radiation therapy (IORT). With a mean follow-up of 55 months, outcomes published in The American Journal of Surgery showed that breast cancer recurrence rates of patients who were treated with IORT using the Xoft System and complied with adjuvant medical therapy were comparable to those seen in the cornerstone TARGIT-A study, which evaluated IORT using different technology.